Susquehanna Portfolio Strategies’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$174K Sell
97,378
-11,066
-10% -$23.5K ﹤0.01% 911
2025
Q4
$243K Sell
108,444
-35,018
-24% -$92.1K ﹤0.01% 916
2025
Q3
$347K Buy
+143,462
New +$382K 0.01% 904

Other funds holding PROK

Susquehanna Portfolio Strategies's PROK Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its ProKidney (PROK) stake by 10% in Q1 2026, selling an estimated $23.5K and leaving 97,378 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #911.

Susquehanna Portfolio Strategies first reported a position in PROK in Q3 2025 and has held it in 3 quarters since. The position peaked at $347K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Susquehanna Portfolio Strategies held 97,378 shares of ProKidney worth $174K as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 11,066 ProKidney shares in Q1 2026, an estimated $23.5K.
  • ProKidney made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #911 holding.
  • Susquehanna Portfolio Strategies first reported a position in ProKidney in Q3 2025 and has held it in 3 quarters since.
  • Susquehanna Portfolio Strategies's ProKidney position peaked at $347K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.